MedPath

External Device for Erectile Dysfunction (3D-Erect)

Not Applicable
Recruiting
Conditions
Erectile Dysfunction
Impotentia Erigendi
Interventions
Device: 3D-Erect
Registration Number
NCT04624126
Lead Sponsor
Stanford University
Brief Summary

The aim of this clinical trial is to test the safety and feasibility of a non-invasive 3D-printed external penile device to achieve successful and satisfactory sexual intercourse in men with erectile dysfunction (ED).

Detailed Description

A clinical trial to test the safety and feasibility of our newly developed non-invasive 3D-printed external penile device for the treatment and recovery of erectile dysfunction.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
9
Inclusion Criteria
  • males >18 years old suffering from any cause moderate to severe erectile dysfunction (e.g. ED after radical prostatectomy and/or radiation therapy for prostate cancer and or other pelvic malignancies affecting the sexual potency; emotional and psychological ED; organic vascular and/or metabolic ED etc.)
  • having a female partner willing to participate in the study.
Read More
Exclusion Criteria
  • not willing to attempt sexual vaginal intercourse with their partner
  • inability to wear/operate the external penile device for any reason
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
3D-Erect arm3D-ErectParticipants will be asked to use the 3D-printed penile device during their intercourse with partners.
Primary Outcome Measures
NameTimeMethod
Change in modified International Index of Erectile Dysfunction scorebaseline and up to 1 month post-baseline

score 0 to 30 with higher score meaning overall better erectile function

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford Health Care, Stanford Hospital

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath